UBS analyst Luiz Carvalho downgrades Ecopetrol (NYSE:EC) from Buy to Neutral.
5 Analysts Have This to Say About Oncolytics Biotech
Analysts have provided the following ratings for Oncolytics Biotech (NASDAQ:ONCY) within the last quarter: Bullish Somewhat Bullish Indifferent…